B. Shenton

D. Mikhailidis, G. Stansby, B. Shenton, 2004, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Ischemia-reperfusion injury in cadaveric nonheart beating, cadaveric heart beating and live donor renal transplants.

N. Soomro, M. Pelsers, B. Shenton, 2006, Journal of Urology.

Use of two biomarkers of renal ischemia to assess machine-perfused non-heart-beating donor kidneys.

M. Pelsers, J. Glatz, B. Shenton, 2003, Clinical chemistry.

Comparison of Glutathione S-Transferase and Alanyl Aminopeptidase as Viability Markers in a Porcine NHBD Model

B. Shenton, D. Mantle, R. Peaston, 2002, Comparative Clinical Pathology.

Improving the quality of kidneys from non-heart-beating donors, using streptokinase: An animal model1

B. Shenton, J. Dark, D. Mantle, 2002, Transplantation.

Standardization of lymphocyte antibody binding capacity - a multi-centre study.

J. Reilly, I. Storie, J. Lawry, 2000, Clinical and laboratory haematology.

MUC1 expression in primary breast cancer: the effect of tamoxifen treatment

J. Hanson, I. Brotherick, W. Cunliffe, 2001, Breast Cancer Research and Treatment.

The relationship between flow-cytometric and immunohistochemically detected c-erbB-2 expression, grade and DNA ploidy in breast cancer

B. Angus, C. Horne, T. Lennard, 1995, Cancer Immunology, Immunotherapy.

Anti-vimentin antibody detection in recipients of heart-beating and non-heart beating donor kidneys.

B. Shenton, A. Gupta, D. Talbot, 2005, Transplantation proceedings.

The clinical significance of post‐transplantation non‐HLA antibodies in renal transplantation

K. Al-Hussein, B. Shenton, G. Proud, 1995 .

The detection and relevance of pretransplant antibodies.

B. Shenton, 1994, Transplant immunology.

Production of immunosuppressive factors by a cultured tumour cell line and their effect on lymphocyte proliferation and cell cycle response.

J. Kirby, K. Rigg, S. Yeaman, 1993, Surgical oncology.

Graft function after kidney transplantation from non-heartbeating donors according to maastricht category.

N. Soomro, B. Shenton, D. Manas, 2004, The Journal of urology.

VIMENTIN ANTIBODIES – A NON-HLA ANTIBODY AS A POTENTIAL RISK FACTOR IN RENAL TRANSPLANTATION

B. Shenton, D. Turner, D. Talbot, 2004, Transplantation proceedings.

Treadmill exercise in claudicants on aspirin results in improved antioxidant status but only minimal platelet activation

M. Cleanthis, G. Stansby, G. Stansby, 2005, Platelets.

THE RELEVANCE OF A MORE SENSITIVE CROSSMATCH ASSAY TO RENAL TRANSPLANTATION

A. Givan, B. Shenton, G. Proud, 1989, Transplantation.

Plasma cell myeloma variant of post-transplant lymphoproliferative disorder in a solid organ transplant recipient: a case report.

B. Shenton, Colin H. Wilson, B. Wilkins, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

A rapid, objective method for the detection of lymphocytotoxic antibodies using flow cytometry.

A. Givan, B. Shenton, G. Proud, 1987, Journal of immunological methods.

Characterization of donor‐directed antibody class in the post‐transplant period using flow cytometry in renal transplantation

K. Al-Hussein, J. Forsythe, K. Rigg, 1994 .

Characterization of donor-directed antibody class in the post-transplant period using flow cytometry in renal transplantation

K. Al-Hussein, J. Forsythe, K. Rigg, 1994, Transplant international : official journal of the European Society for Organ Transplantation.

Depression of cellular immunity as an index of malnutrition in surgical patients

B. Shenton, D. Francis, 1981 .

DR typing in less than three hours using a flow cytometer.

A. Givan, B. Shenton, G. Proud, 1988, Transplantation proceedings.

Changes in EBV gene load in renal transplant recipients.

B. Shenton, K. Gould, E. Leung, 2003, Transplantation Proceedings.

Immune monitoring of anti-thymocyte globulin (ATG) treatment in transplant patients

B. Shenton, J. Dark, D. Manas, 2001 .

Experiences learned in the successful establishment of a nonheart beating donor program for renal transplantation.

B. Shenton, D. Talbot, M. Gok, 2003, The Journal of urology.

IMMUNOSUPPRESSION BY HUMAN α2‐MACROGLOBULIN, A 3800 Mr PEPTIDE, AND OTHER DERIVATIVES a

A. Balber, B. Shenton, G. Proud, 1983 .

Expression of chemokine receptors CXCR1 and CXCR2 during cardiopulmonary bypass.

J. Kirby, P. Kesteven, B. Shenton, 2001, The Journal of thoracic and cardiovascular surgery.

The effect of inadequate in situ perfusion in the non heart‐beating donor

N. Soomro, B. Shenton, D. Talbot, 2005, Transplant international : official journal of the European Society for Organ Transplantation.

Re-evaluation of viability testing of cadaveric kidneys for transplantation.

B. Shenton, C. P. Newman, 1981, British journal of urology.

Use of real-time PCR to measure Epstein-Barr virus genomes in whole blood.

C. Yap, F. K. Gould, B. Shenton, 2002, Journal of immunological methods.

Growth dysregulation and p53 accumulation in human primary colorectal cancer

F. Campbell, I. Brotherick, B. Shenton, 1999, British Journal of Cancer.

VIMENTIN ANTIBODIES – A NON-HLA ANTIBODY AS A POTENTIAL RISK FACTOR IN RENAL TRANSPLANTATION

C. Chapman, B. Shenton, D. Turner, 2004 .

Randomized clinical trial of omega-3 fatty acid-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery

C. Seal, J. Kirby, S. Preston, 2012, The British journal of surgery.

KGF suppresses α2β1 integrin function and promotes differentiation of the transient amplifying population in human prostatic epithelium

C. Robson, H. Leung, R. Heer, 2006, Journal of Cell Science.

KGF suppresses alpha2beta1 integrin function and promotes differentiation of the transient amplifying population in human prostatic epithelium.

C. Robson, H. Leung, R. Heer, 2006, Journal of cell science.

Immunoelectrophoretic pattern of a2-macroglobulin and a2-macroglobulin-protease complexes

M. F. White, P. Donnelly, B. Shenton, 1990 .

THE VALUE OF POSTTRANSPLANT MONITORING OF INTERLEUKIN (IL)-2, IL‐3, IL‐4, IL‐6, IL‐8, AND SOLUBLE CD23 IN THE PLASMA OF RENAL ALLOGRAFT RECIPIENTS

J. Forsythe, K. Rigg, N. Kutukculer, 1995, Transplantation.

Alpha 2-macroglobulin and generation of oxygen radicals by granulocytes: potential role in prevention and treatment of reperfusion injury.

B. Shenton, P. Donnelly, M. White, 1991, Clinica chimica acta; international journal of clinical chemistry.

Fat emulsion adversely affects lymphocyte reactivity.

B. Shenton, D. Francis, DavidM. A. Francis, 1987, The Australian and New Zealand journal of surgery.

The paradox of ATG monitoring in renal transplantation.

J. Forsythe, K. Rigg, M. White, 1994, Transplantation proceedings.

Importance of methodology in the flow cytometric crossmatch: a multicentre study.

D. Waters, P. R. Evans, B. Shenton, 1997, Transplantation proceedings.

The prospective value of the preoperative flow cytometric crossmatch assay in renal transplantation.

A. Givan, J. Forsythe, K. Rigg, 1990, Transplantation.

Evaluation of the flow cytometric crossmatch. Preliminary results of a multicenter study.

P. R. Evans, B. Shenton, T. Horsburgh, 1996, Transplantation.

Flow cytometric crossmatching and outcome one year after renal transplantation.

A. Givan, B. Shenton, G. Proud, 1992, Transplant international : official journal of the European Society for Organ Transplantation.

A flow cytometric study of c-erbB-3 expression in breast cancer

B. Angus, C. Horne, T. Lennard, 1995, Cancer Immunology, Immunotherapy.

Mechanisms in chronic inflammation.

B. Shenton, P. Donnelly, 1984, Immunology today.

Purification and properties of a lymphocyte inhibition factor from human serum.

B. Shenton, E. A. Caspary, W. Ford, 1973, Clinical and experimental immunology.

Inhibition of natural killing and antibody-dependent cell-mediated cytotoxicity by the plasma protease inhibitor α2-macroglobulin (α2M) and α2M protease complexes

B. Shenton, A. Dickinson, S. Proctor, 1985 .

Renal transplants from non‐heart beating paracetamol overdose donors

N. Soomro, B. Shenton, P. Olschewski, 2004, Clinical transplantation.

Plasma interleukin 2 receptor levels in renal allograft dysfunction.

J. Forsythe, B. Shenton, G. Proud, 1989, Transplantation.

CMV infection as a contributory factor for renal allograft injury and loss.

B. Shenton, C. Gerstenkorn, H. Robertson, 2001, Transplantation proceedings.

Analysis of peripheral blood T-cell subsets in active thyroid-associated ophthalmopathy: absence of effect of octreotide-LAR on T-cell subsets in patients with thyroid-associated ophthalmopathy.

P. Perros, B. Vaidya, P. Kendall‐Taylor, 2005, Thyroid : official journal of the American Thyroid Association.

Expression of oestrogen and progesterone receptors in gastric cancer: a flow cytometric study

I. Brotherick, B. Shenton, S. Griffin, 1999, British Journal of Cancer.

Neutrophil chemotaxis and receptor expression in clinical septic shock

J. Kirby, B. Shenton, S. Baudouin, 2004, Intensive Care Medicine.

Cardiovascular risk assessment scoring system for the determination of cardiovascular mortality in renal transplant patients.

B. Shenton, A. Gupta, D. Talbot, 2005, Transplantation Proceedings.

Use of the monoclonal antibody DAKO-ERβ (8D5-1) to measure oestrogen receptor beta in breast cancer cells

P. Scorer, I. Brotherick, D. Browell, 2001 .

p53 expression measured by flow cytometry. A comparison of three monoclonal antibodies and the relationship with grade and DNA ploidy in breast cancer

B. Angus, C. Horne, T. Lennard, 1995, Cancer Immunology, Immunotherapy.

DNA analysis and parathyroid pathology

J. Farndon, B. Shenton, I. Johnston, 1990, World Journal of Surgery.

The flow cytometric crossmatch in liver transplantation.

M. Thick, P. Gibbs, B. Shenton, 1995, Transplantation.

Machine perfusion and viability assessment of non-heart-beating donor kidneys-a single-centre result.

N. Soomro, B. Shenton, D. Mantle, 2001, Transplantation Proceedings.

Use of flow cytometric crossmatching in cardiac transplantation.

A. Givan, A. Mitcheson, B. Shenton, 1991, Transplantation proceedings.

Rapid detection of low levels of donor specific IgG by flow cytometry with single and dual colour fluorescence in renal transplantation.

A. Givan, B. Shenton, G. Proud, 1988, Journal of immunological methods.

Value of the flow cytometric crossmatch in renal transplantation.

A. Givan, T. Lennard, B. Shenton, 1987, Transplantation proceedings.

Use of thrombolytic streptokinase as a preflush in the NHBD procurement.

N. Soomro, B. Shenton, D. Mantle, 2003, Transplantation Proceedings.

Blood transfusion and renal transplantation

B. Shenton, B. Shenton, G. Proud, 1979, The British journal of surgery.

Lectin ELISA for the c-erb-B2 tumor marker protein p185 in patients with breast cancer and controls.

D. Cook, C. Self, I. Brotherick, 1999, Clinical chemistry.

Value of flow cytometric monitoring of posttransplant antibody status in renal transplantation.

K. Al-Hussein, J. Forsythe, K. Rigg, 1993, Transplantation Proceedings.

Tumour cell dissemination following endoscopic stent insertion

B. Shenton, B. Shenton, G. Lash, 2007, The British journal of surgery.

Does donor cardiopulmonary resuscitation time affect outcome in uncontrolled non-heart-beating donor renal transplants?

N. Soomro, B. Shenton, J. Watson, 2005, Transplantation Proceedings.

Transfusion‐induced immunosuppression and red cell clearance

B. Shenton, B. Shenton, G. Proud, 1991, Transfusion medicine.

Renal allograft rejection: expression and function of VCAM‐1 on tubular epithelial cells

A. Morley, J. Kirby, B. Shenton, 1993, Clinical and experimental immunology.

Breast

A. Givan, J. Henry, B. Shenton, 2021, Proceedings of UK Radiological Conference 2021.

TRANSFUSION EFFECT IN RENAL TRANSPLANTS

B. Shenton, G. Proud, R. Taylor, 1982, The Lancet.

Renal allograft rejection: induction and function of adhesion molecules on cultured epithelial cells

J. Kirby, J. Forsythe, Y. Lin, 1992, Clinical and experimental immunology.

Renal allograft rejection: the temporal relationship and predictive value of plasma TNF (alpha and beta), IFN-gamma and soluble ICAM-1

N. Kutukculer, B. Shenton, G. Proud, 1995, Transplant international : official journal of the European Society for Organ Transplantation.

The value of plasma-soluble interleukin 2 receptor monitoring in lung transplantation.

A. Gascoigne, P. Corris, J. Dark, 1993, Transplantation.

Alterations in circulating lymphocyte number and function after circulation through colorectal carcinomas.

K. Rigg, T. Lennard, I. Brotherick, 1991, Surgery.

Weight increase during machine perfusion may be an indicator of organ and in particular, vascular damage.

B. Shenton, A. Gupta, S. Balupuri, 2004, Annals of transplantation.